SE8505920D0 - New protein and its use - Google Patents

New protein and its use

Info

Publication number
SE8505920D0
SE8505920D0 SE8505920A SE8505920A SE8505920D0 SE 8505920 D0 SE8505920 D0 SE 8505920D0 SE 8505920 A SE8505920 A SE 8505920A SE 8505920 A SE8505920 A SE 8505920A SE 8505920 D0 SE8505920 D0 SE 8505920D0
Authority
SE
Sweden
Prior art keywords
gly
phe
leu
protein
tyr
Prior art date
Application number
SE8505920A
Other languages
English (en)
Swedish (sv)
Inventor
V R Sara
Original Assignee
Kabigen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabigen Ab filed Critical Kabigen Ab
Priority to SE8505920A priority Critical patent/SE8505920D0/xx
Publication of SE8505920D0 publication Critical patent/SE8505920D0/xx
Priority to EP86850417A priority patent/EP0227619A3/fr
Priority to AU66330/86A priority patent/AU6633086A/en
Priority to DK600586A priority patent/DK600586A/da
Priority to JP61296511A priority patent/JPS62187500A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8505920A 1985-12-13 1985-12-13 New protein and its use SE8505920D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8505920A SE8505920D0 (sv) 1985-12-13 1985-12-13 New protein and its use
EP86850417A EP0227619A3 (fr) 1985-12-13 1986-12-02 Protéine et son application
AU66330/86A AU6633086A (en) 1985-12-13 1986-12-09 Human fetal somatomedin
DK600586A DK600586A (da) 1985-12-13 1986-12-12 Protein
JP61296511A JPS62187500A (ja) 1985-12-13 1986-12-12 新規蛋白質及びその使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505920A SE8505920D0 (sv) 1985-12-13 1985-12-13 New protein and its use

Publications (1)

Publication Number Publication Date
SE8505920D0 true SE8505920D0 (sv) 1985-12-13

Family

ID=20362466

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8505920A SE8505920D0 (sv) 1985-12-13 1985-12-13 New protein and its use

Country Status (5)

Country Link
EP (1) EP0227619A3 (fr)
JP (1) JPS62187500A (fr)
AU (1) AU6633086A (fr)
DK (1) DK600586A (fr)
SE (1) SE8505920D0 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81779T1 (de) * 1985-08-22 1992-11-15 Gropep Pty Ltd Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
JP2507106B2 (ja) * 1987-12-24 1996-06-12 グロペップ プロプライエタリー リミテッド インスリン様成長因子１（ｉｇｆ―１）または因子２（ｉｇｆ―２）の類縁ペプチド
US5470828A (en) * 1987-12-24 1995-11-28 Gropep Pty. Ltd. Peptide analogs of insulin-like growth factor II
US6693076B1 (en) 1989-06-05 2004-02-17 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
US6723699B1 (en) 1989-06-05 2004-04-20 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
US5093317A (en) * 1989-06-05 1992-03-03 Cephalon, Inc. Treating disorders by application of insulin-like growth factor
US5652214A (en) * 1989-06-05 1997-07-29 Cephalon, Inc. Treating disorders by application of insulin-like growth factors and analogs
ES2092502T3 (es) * 1989-10-03 1996-12-01 Exxon Chemical Patents Inc Copolimeros funcionalizados de para-alquilestireno/isoolefina preparados mediante sustitucion nucleofilica.
US5679771A (en) * 1990-02-13 1997-10-21 Gropep Pty. Ltd. Method for treating intestinal diseases
US6310040B1 (en) * 1991-11-08 2001-10-30 Cephalon, Inc. Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs
JPH09509140A (ja) * 1993-11-15 1997-09-16 セルトリックス ファーマシューティカルズ，インコーポレイテッド 神経学的障害の治療方法
ATE435852T1 (de) 2001-05-24 2009-07-15 Neuren Pharmaceuticals Ltd Gpe-analoga und peptidomimetika
US7714020B2 (en) 2001-05-24 2010-05-11 Neuren Pharmaceuticals Limited Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
US7605177B2 (en) 2001-05-24 2009-10-20 Neuren Pharmaceuticals Limited Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81779T1 (de) * 1985-08-22 1992-11-15 Gropep Pty Ltd Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.

Also Published As

Publication number Publication date
DK600586D0 (da) 1986-12-12
EP0227619A3 (fr) 1989-12-13
JPS62187500A (ja) 1987-08-15
AU6633086A (en) 1987-06-18
EP0227619A2 (fr) 1987-07-01
DK600586A (da) 1987-06-14

Similar Documents

Publication Publication Date Title
ATE305036T1 (de) Wachstums-differenzierungsfaktor-11
DE3856588D1 (de) Biologisch-aktive Bakterizide/permeabilitätserhöhende Proteinbruchstücke
CA2080462A1 (fr) Utilisation therapeutique de composes liant l'actine
ATE196147T1 (de) Wachstumsdifferenzierungsfaktor-12
DE3750113D1 (de) Für menschliche "Colony-stimulating"-Faktoren kodierendes Gen.
DK163930C (da) Biologisk aktivt peptid og peptidfragment deraf med natriuretisk, diuretisk og vasodilataterende aktivitet og terapeutisk middel indeholdende et saadant peptid eller peptidfragment
EP0227619A3 (fr) Protéine et son application
ATE111518T1 (de) Dna-klon für menschlichen gewebefaktorinhibitor.
DE3584579D1 (de) Herstellung von polypeptiden mit human-gammainterferon-aktivitaet.
BG49827A3 (bg) Метод за получаване на пречистен биологично активен рекомбинантен човешки колоний стимулиращ фактор
ATE91625T1 (de) Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren.
FI864552A0 (fi) Human-lysozym.
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
NZ230155A (en) N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions
JPS5779897A (en) Polypeptide containing amino acid arrangement of aged human corpuscle interferone
FI885295L (fi) Substituoituja dikarboksyylihappo-bis(3,5-dikarbamoyyli-2,4,6-trijodianilideja) menetelmä niiden valmistamiseksi sekä niiden käyttö röntgenvarjoaineiden valmistamiseksi
DE3689921D1 (de) Menschlicher plazentarer angiogenischer Faktor, geeignet für die Reizung der Kapillarsynthese, der Endothelzellprotease, der DNS-Synthese und der Absiedlung.
DE3689084D1 (de) Verfahren zur in vitro-diagnose von boesartigen zellen aus dem verdauungstrakt.
DE69306273D1 (de) Mitogen für die glatte Muskulatur und dessen kodierende DNS
IT8567469A0 (it) Procedimento per la preparazionedi n benzilossicarbonil amminoacidi contenenti funzionalita addizionali
IT7951108A0 (it) Procedimento per la preparazione di cloridrati di amminoacidi e biclori drati di diamminoacidi
NO164100C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-klor-s-triazolo-(4,3-a)-pyridin-7-carboxyl-syrer.
FR2633628B1 (fr) Procede de preparation de polylactones d'acides poly-((alpha)-hydroxy-(acryliques et/ou crotoniques))
ATA339087A (de) Polypeptid-zusammensetzung, die für die herstellung von antimalaria-vakzinen und diagnostischen ausrüstungen für den nachweis von antimerozoit-antikörpern nützlich ist